BiotechTube
Home/Finvector Vision Therapies/Armin Metzger
AM

Armin Metzger

Vice Chair, Board Member

Finvector Vision Therapies

Therapeutic Areas

OphthalmologyOncology

Finvector Vision Therapies Pipeline

DrugIndicationPhase
Non-Muscle Invasive Bladder Cancer Therapy (likely nadofaragene firadenovec/Adstiladrin)Non-Muscle Invasive Bladder CancerApproved

Leadership Team at Finvector Vision Therapies

GC
Giuseppe Carloni
Chairman of the Board
BD
Bipin Dalmia
Board Member
View full Finvector Vision Therapies profile